{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:00:29Z","timestamp":1773284429741,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,5,15]],"date-time":"2012-05-15T00:00:00Z","timestamp":1337040000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Extended spectrum \u03b2-lactamase (ESBL) producing <jats:italic>Enterobacteriaceae<\/jats:italic> infections are associated with delayed initiation of appropriate treatment, poor outcomes and increased hospital stay and expense. Although initially associated with healthcare settings, more recent international reports have shown increasing isolation of ESBLs in the community. Both hospital and community ESBL epidemiology in Ireland are poorly defined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This report describes clinical and laboratory data from three hospitals over 4.5\u2009years. All significant isolates of <jats:italic>Enterobacteriaceae<\/jats:italic> were subjected to standardized antimicrobial susceptibility testing and screening for ESBL production. Available patient data from hospital databases were reviewed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The database included 974 ESBL producing organisms from 464 patients. Urine and blood isolates represented 84% and 3% of isolates respectively. <jats:italic>E. coli<\/jats:italic> predominated (90.9%) followed by <jats:italic>K. pneumoniae<\/jats:italic> (5.6%). The majority of patients (n\u2009=\u2009246, 53.0%) had been admitted to at least one of the study hospitals in the year prior to first isolation of ESBL. The overall 30-day all-cause mortality from the date of culture positivity was 9.7% and the 1\u2009year mortality was 61.4%. A Cox regression analysis showed age over 60, male gender and previous hospital admissions were significant risk factors for death within 30\u2009days of ESBL isolation. Numbers of ESBL-producing <jats:italic>E. coli<\/jats:italic> isolated from urine and blood cultures increased during the study. Urine isolates were more susceptible than blood isolates. Co-resistance to other classes of antimicrobial agents was more common in ESBL producers from residents of long stay facilities (LSF) compared with hospital inpatients who lived at home.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This work demonstrates a progressively increasing prevalence of ESBL <jats:italic>Enterobacteriaceae<\/jats:italic> in hospital, LSF and community specimens in a defined catchment area over a long time period . These results will improve clinician awareness of this problem and guide the development of empiric antimicrobial regimens for community acquired bloodstream and urinary tract infections.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-12-116","type":"journal-article","created":{"date-parts":[[2012,5,15]],"date-time":"2012-05-15T15:45:31Z","timestamp":1337096731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Increasing prevalence of ESBL production among Irish clinical Enterobacteriaceae from 2004 to 2008: an observational study"],"prefix":"10.1186","volume":"12","author":[{"given":"J\u00e9r\u00f4me","family":"Fennell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akke","family":"Vellinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belinda","family":"Hanahoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dearbhaile","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deirbhile","family":"Keady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Cormican","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,15]]},"reference":[{"key":"1977_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/BF01641355","volume":"11","author":"H Knothe","year":"1983","unstructured":"Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S: Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection. 1983, 11: 315-317. 10.1007\/BF01641355.","journal-title":"Infection"},{"key":"1977_CR2","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1128\/AAC.48.12.4574-4581.2004","volume":"48","author":"CI Kang","year":"2004","unstructured":"Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW: Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother. 2004, 48: 4574-4581. 10.1128\/AAC.48.12.4574-4581.2004.","journal-title":"Antimicrob Agents Chemother"},{"key":"1977_CR3","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1128\/JCM.39.6.2206-2212.2001","volume":"39","author":"DL Paterson","year":"2001","unstructured":"Paterson DL, Ko WC, von Gottenberg A, Casellas JM, Mulazimoglu L, Klugman KP, Bonomo RA, Rice L, McCormack JG, Yu VL: Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol. 2001, 39: 2206-2212. 10.1128\/JCM.39.6.2206-2212.2001.","journal-title":"J Clin Microbiol"},{"key":"1977_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/420816","volume":"39","author":"DL Paterson","year":"2004","unstructured":"Paterson DL, Ko WC, von Gottenberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA Rice LB, Wagener MM, McCormack JG, Yu VL: Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis. 2004, 39: 31-37. 10.1086\/420816.","journal-title":"Clin Infect Dis"},{"key":"1977_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1046\/j.1365-2672.2000.00989.x","volume":"88","author":"N Mangeney","year":"2000","unstructured":"Mangeney N, Niel P, Paul G, Faubert E, Hue S, Dupeyron C, Louarn F, Leluan G: A 5-year epidemiological study of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a medium- and long-stay neurological unit. J Appl Microbiol. 2000, 88: 504-511. 10.1046\/j.1365-2672.2000.00989.x.","journal-title":"J Appl Microbiol"},{"key":"1977_CR6","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1086\/319757","volume":"32","author":"E Lautenbach","year":"2001","unstructured":"Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO: Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001, 32: 1162-1171. 10.1086\/319757.","journal-title":"Clin Infect Dis"},{"key":"1977_CR7","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1086\/507962","volume":"27","author":"SY Lee","year":"2006","unstructured":"Lee SY, Kotapati S, Kuti JL, Nightingale CH, Nicolau DP: Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study. Infect Control Hosp Epidemiol. 2006, 27: 1226-1232. 10.1086\/507962.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1977_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/jac\/dki239","volume":"56","author":"DM Livermore","year":"2005","unstructured":"Livermore DM, Hawkey PM: CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother. 2005, 56: 451-454. 10.1093\/jac\/dki239.","journal-title":"J Antimicrob Chemother"},{"key":"1977_CR9","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1128\/AAC.47.11.3506-3514.2003","volume":"47","author":"C Arpin","year":"2003","unstructured":"Arpin C, Dubois V, Coulange L, Andre C, Fischer I, Noury P, Grobost F, Brochet JP, Jullin J, Dutilh B, Couture JF, Noury P, Lagrange I, Ducastaing A, Doermann HP, Quentin C: Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrob Agents Chemother. 2003, 47: 3506-3514. 10.1128\/AAC.47.11.3506-3514.2003.","journal-title":"Antimicrob Agents Chemother"},{"key":"1977_CR10","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1128\/AAC.34.11.2193","volume":"34","author":"LB Rice","year":"1990","unstructured":"Rice LB, Willey SH, Papanicolaou GA, Medeiros AA, Eliopoulos GM, Moellering RC, Jacoby GA: Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother. 1990, 34: 2193-2199. 10.1128\/AAC.34.11.2193.","journal-title":"Antimicrob Agents Chemother"},{"key":"1977_CR11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1001\/jama.281.6.517","volume":"281","author":"J Wiener","year":"1999","unstructured":"Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, Weinstein RA: Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA. 1999, 281: 517-523. 10.1001\/jama.281.6.517.","journal-title":"JAMA"},{"key":"1977_CR12","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/jac\/dkh424","volume":"54","author":"N Woodford","year":"2004","unstructured":"Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, Johnson AP, Pike R, Warner M, Cheasty T, Pearson A, Harry S, Leach JB, Loughrey A, Lowes JA, Warren RE, Livermore DM: Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother. 2004, 54: 735-743. 10.1093\/jac\/dkh424.","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"1977_CR13","first-page":"ii41","volume":"62","author":"DM Livermore","year":"2008","unstructured":"Livermore DM, Hope R, Brick G, Lillie M, Reynolds R: Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001\u201306. J Antimicrob Chemother. 2008, 62 (Suppl 2): ii41-54. ii41-ii54","journal-title":"J Antimicrob Chemother"},{"key":"1977_CR14","first-page":"111","volume":"55","author":"J Grogan","year":"1998","unstructured":"Grogan J, Murphy H, Butler K: Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Dublin paediatric hospital. Br J Biomed Sci. 1998, 55: 111-117.","journal-title":"Br J Biomed Sci"},{"key":"1977_CR15","unstructured":"Health Protection Surveillance Centre Annual Report. 2007, [http:\/\/www.hpsc.ie\/hpsc\/AboutHPSC\/AnnualReports\/File,3377,en.pdf]"},{"key":"1977_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/BF03168974","volume":"174","author":"M NiChulain","year":"2005","unstructured":"NiChulain M, Murray AM, Corbett-Feeney G, Cormican M: Antimicrobial resistance in E.coli associated with urinary tract infection in the west of Ireland. Ir J Med Sci. 2005, 174: 6-9. 10.1007\/BF03168974.","journal-title":"Ir J Med Sci"},{"key":"1977_CR17","first-page":"3","volume":"6","author":"D Morris","year":"2005","unstructured":"Morris D, Murphy A, Pickup M, Hanahoe B, Fenelon L, Cormican M: Recognition of Cefotaximase ProducingE. colias a Urinary Tract Pathogen in Ireland. EPI-Insight. 2005, 6: 3-4.","journal-title":"EPI-Insight"},{"key":"1977_CR18","first-page":"E060831","volume":"11","author":"H Pelly","year":"2006","unstructured":"Pelly H, Morris D, O'Connell E, Hanahoe B, Chambers C, Biernacka K, Gray S, Cormican M: Outbreak of extended spectrum beta-lactamase producingE. coliin a nursing home in Ireland, May 2006. Euro Surveill. 2006, 11: E060831-","journal-title":"Euro Surveill"},{"key":"1977_CR19","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Eighth Informational Supplement . CLSI document M100-S8.1998 Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania."},{"key":"1977_CR20","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. CLSI document M100-S21 (ISBN 1-56238-742-1). Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087 USA, 2011."},{"key":"1977_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jinf.2006.01.004","volume":"54","author":"R McMullan","year":"2007","unstructured":"McMullan R, Loughrey AC, McCalmont M, Rooney PJ: Clinico-epidemiological features of infections caused by CTX-M type extended spectrum beta lactamase-producing Escherichia coli in hospitalised patients. J Infect. 2007, 54: 46-52. 10.1016\/j.jinf.2006.01.004.","journal-title":"J Infect"},{"key":"1977_CR22","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1128\/AAC.00171-08","volume":"52","author":"P Kiratisin","year":"2008","unstructured":"Kiratisin P, Apisarnthanarak A, Laesripa C, Saifon P: Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother. 2008, 52: 2818-2824. 10.1128\/AAC.00171-08.","journal-title":"Antimicrob Agents Chemother"},{"key":"1977_CR23","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1128\/JCM.42.3.1089-1094.2004","volume":"42","author":"J Rodriguez-Bano","year":"2004","unstructured":"Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, Perez-Cano R, Pascual A: Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol. 2004, 42: 1089-1094. 10.1128\/JCM.42.3.1089-1094.2004.","journal-title":"J Clin Microbiol"},{"key":"1977_CR24","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1128\/JCM.37.12.4065-4070.1999","volume":"37","author":"FC Tenover","year":"1999","unstructured":"Tenover FC, Mohammed MJ, Gorton TS, Dembek ZF: Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut. J Clin Microbiol. 1999, 37: 4065-4070.","journal-title":"J Clin Microbiol"},{"key":"1977_CR25","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1086\/648453","volume":"30","author":"E O'Fallon","year":"2009","unstructured":"O'Fallon E, Schreiber R, Kandel R, D'Agata EM: Multidrug-resistant gram-negative bacteria at a long-term care facility: assessment of residents, healthcare workers, and inanimate surfaces. Infect Control Hosp Epidemiol. 2009, 30: 1172-1179. 10.1086\/648453.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1977_CR26","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1086\/604713","volume":"49","author":"R Ben-Ami","year":"2009","unstructured":"Ben-Ami R, Rodriguez-Bano J, Arslan H, Pitout JD, Quentin C, Calbo ES, Azap OK, Arpin C, Pascual A, Livermore DM, Garau J, Carmeli Y: A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis. 2009, 49: 682-690. 10.1086\/604713.","journal-title":"Clin Infect Dis"},{"key":"1977_CR27","unstructured":"Royal College of Physicians of Ireland. Policy Group on Healthcare-Associated Infection (HCAI): 2009, Antibiotic Use And The Implications For Healthcare-Associated Infection. Dublin, http:\/\/www.rcpi.ie\/News\/Documents\/AntibioticUseandImplicationsforHCAI.pdf,"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-116\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:49:02Z","timestamp":1630525742000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,15]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1977"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-116","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,15]]},"assertion":[{"value":"4 October 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"116"}}